Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Ozelle Unveils AI-Powered Complete Blood Morphology Solution
The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.
Flow Cytometry
Latest
Watchmaker Genomics Licenses CRISPR Technology to Improve DNA Sequencing Efficiency
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Mass Spectrometry
Latest
FDA Grants Breakthrough Status to Breath Test for Postoperative Pneumonia Risk
The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.'s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.
Immunoassay
Latest
QuidelOrtho Partners with Lifotronic to Expand Global Immunoassay Testing Portfolio
QuidelOrtho has signed a supply agreement with Lifotronic to add multiple analyzer platforms and over 25 new immunoassays, expanding its testing portfolio in international markets outside the US.
Molecular Diagnostics
Latest
Alithea Genomics Raises $8.9 Million to Scale RNA Sequencing for Drug Discovery
Swiss company's 1536-well technology aims to make transcriptomics cost-effective for primary drug screening and toxicology applications.
Point-of-Care
Latest
Roche Receives FDA Clearance for Point-of-Care Bordetella Test
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.